DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a different medical use and route of administration. The novel formulation will manage undesirable side effects resulting from neurotoxin injections in both medical and cosmetic applications.
ConveyMED is an Ed Tech Marketplace and the first podcast platform designed specifically for Professional Education. Busy physicians, nurses, pharmacists and other professionals want...
iVizz, is a Bay Area technology company which enables hospitals to prevent in-patient infections outbreaks.https://www.angelmd.co/en/startups/ivizz
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...
